共 50 条
- [1] Pioglitazone improves diabetic dyslipidaemia in patients with type 2 diabetes mellitus with or without lipid-lowering therapy[J]. Clinical Drug Investigation, 2005, 25 (5) : 341 - 345Schöfl C.Luebben G.
- [2] Pioglitazone improves diabetic dyslipidaemia in patients with type 2 diabetes mellitus with or without lipid-lowering therapy[J]. CLINICAL DRUG INVESTIGATION, 2005, 25 (05) : 341 - 345Schöfl, CLuebben, G
- [3] Pioglitazone in renal dialysis patients with type-2-diabetes mellitus[J]. DIABETES, 2005, 54 : A508 - A508Degenhardt, SSchmidt, GBKaragiannis, ELuebben, G
- [4] Pioglitazone improves metabolic control and lowers blood pressure in patients with type-2-diabetes mellitus[J]. DIABETES, 2003, 52 : A459 - A459Gerber, PPGLuebben, GHeusler, SDodo, AVornbaeumen, J
- [5] Pioglitazone reduces blood pressure in patients with type-2-diabetes mellitus[J]. DIABETES, 2001, 50 : A462 - A462Scherbaum, WGöke, B
- [6] The case history: Combination therapy of the Type-2-Diabetes mellitus with Insulin and Pioglitazone[J]. DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (03) : 146 - 147Lundershausen, Rainer
- [7] The case history: Combination therapy of the Type-2-Diabetes mellitus with Insulin and Pioglitazone - Commentary[J]. DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (03) : 147 - 148Lundershausen, RainerGallwitz, Baptist
- [8] Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus[J]. AMERICAN JOURNAL OF MEDICINE, 2005, 118 : 10S - 15SBetteridge, J
- [9] Adding pioglitazone to metformin therapy improves the lipid profile in patients with type 2 diabetes[J]. DIABETES, 1999, 48 : A106 - A107Egan, JRubin, CMathisen, A
- [10] Dyslipidemia in Type-2-Diabetes: Pioglitazone shows significant Lipid Benefit[J]. JOURNAL FUR KARDIOLOGIE, 2005, 12 (9-10): : 272 - 274Tatschl, Christian